Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
NCT01443676Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Oct 2011
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in glioblastoma (GBM), sponsored by University of Zurich. Started Oct 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01443676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443676.